首頁 > 市場調查報告書 > 醫療設備

居家醫療

市場調查報告書

商品編碼

1574053

居家醫療的全球市場:2024-2034年

Home Healthcare Market Report 2024-2034

出版日期: 2024年10月08日 | 出版商:

Visiongain | 英文 370 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2034 年，全球家庭醫療保健市場規模將以 9.2% 的複合年增長率成長。

科技的進步和對居家照護選擇的認識的提高推動了顯著的成長

技術進步正在顯著推動家庭醫療保健市場的成長，特別是透過遠距醫療和遠端患者監控等創新。這些技術使醫療保健提供者能夠遠端管理患者，從而實現即時幹預，從而改善結果並降低醫療成本。智慧感測器、遠距醫療平台和醫療設備等遠端監控解決方案正在推動全球對家庭醫療保健服務的需求，因為它們為傳統護理提供了更方便、更有效率的替代方案。

此外，人們對家庭護理選擇的認識不斷提高，可支配收入不斷增加，正在加速家庭護理的採用，特別是在老年人和臥床不起的患者中。與傳統住院護理相比，這些服務不僅減少了再入院率，還提高了康復率。公司現在將重點放在印度和中國等新興市場，以抓住這一不斷增長的需求。

家庭醫療保健市場繼續以服務業為主，預計到 2024 年將佔收入佔有率超過 60%。這一類別是根據是否有專門技能來劃分的。熟練服務由持有執照的醫療保健專業人員提供，而非熟練服務提供非醫療支持，例如基本幫助和個人護理，以幫助患者在家中日常生活。醫院費用的上漲預計將進一步增加對熟練護理服務的需求。

熟練護理服務涉及醫療專業人員，例如醫生、註冊護士、物理治療師和專業護理人員，他們在家庭環境或專用護理機構中提供基本護理。隨著患有糖尿病和心血管疾病等慢性病的老年人數量增加，對藥物管理和持續監測等基本醫療服務的需求不斷增加。由於醫療技術的進步，許多治療現在可以在家中進行，為患者提供了更舒適、更方便的護理環境。這極大地促進了更廣泛的家庭健康市場中熟練家庭護理服務的成長。

本報告提供全球居家醫療的市場調查，彙整市場概要，影響市場成長因素及市場機會分析，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

主要調查結果
影響分析
市場推動要素
- 對經濟高效且以患者為中心的醫療保健解決方案的需求不斷增加
- 遠距醫療和遠端監控設備的技術進步
- 需要持續居家照護的慢性疾病增加
- 尋求居家照護的長者數量增加
- 政府促進家庭醫療保健服務的支持措施
阻礙市場要素
- 有關家庭醫療保健服務報銷政策的問題
- 影響居家照護產品核准和使用的監管障礙
- 病人對居家醫療保健解決方案的認知與接受程度
市場機會
- 擴展數位醫療解決方案以增強遠距患者管理
- 擴大醫療保健提供者與科技公司之間的合作關係
- 對預防保健和健康計劃的興趣日益濃厚
新興市場與大趨勢
波特的五力分析
PEST分析

第4章居家醫療市場分析:各類型

主要調查結果
市場魅力指數
市場規模的轉變·預測
產品
服務
- 市場規模的轉變·預測:各地區
- 市場佔有率:各地區

第5章居家醫療市場分析:各適應症

主要調查結果
市場魅力指數
市場規模的轉變·預測
心血管疾病·高血壓
糖尿病·腎臟疾病
神經疾病·精神疾病
呼吸疾病·COPD
母體的異常
異動症
癌症
創傷護理
其他
- 市場規模的轉變·預測:各地區
- 市場佔有率:各地區

第6章居家醫療市場分析:各地區

主要調查結果
市場規模的轉變·預測

第7章北美的居家醫療市場分析

第8章歐洲的居家醫療市場分析

第9章亞太地區的居家醫療市場分析

第10章南美的居家醫療市場分析

第11章中東·非洲的居家醫療市場分析

第12章企業簡介

Abbott
Amedisys
Owens &Minor, Inc.
B. Braun Medical Ltd.
Baxter
BAYADA Home Health Care
ResMed
Koninklijke Philips N.V.
Fisher &Paykel Healthcare Limited
Fresenius Medical Care AG
GE HealthCare
Johnson &Johnson Services, Inc.
OMRON Corporation
McKesson Medical-Surgical Inc.
Medline
Medtronic
3M Health Care
ARKRAY, Inc.
BD
Invacare Corporation
Hollister Incorporated
Convatec Group PLC
Molnlycke AB

第13章總論·建議

Visiongain的總論
市場參與企業的建議

簡介目錄圖表

Product Code: PHA1359

The global Home Healthcare market is projected to grow at a CAGR of 9.2% by 2034

The Home Healthcare Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Technology and Rising Awareness of Home Care Options are Driving Significant Growth

Technological advancements are significantly driving the growth of the home healthcare market, particularly through innovations like telemedicine and remote patient monitoring. These technologies allow healthcare providers to manage patients remotely, enabling real-time interventions that improve outcomes and lower healthcare costs. Remote monitoring solutions, including smart sensors, telehealth platforms, and medical devices, are boosting global demand for home healthcare services as they offer more convenient and efficient alternatives to traditional care.

Additionally, rising awareness of home care options, coupled with growing disposable incomes, is accelerating the adoption of home healthcare, especially among elderly or bedridden patients. These services not only reduce hospital readmissions but also improve recovery rates compared to conventional inpatient care. Companies are now focusing on emerging markets, such as India and China, to capture this growing demand.

Segment Analysis

The services segment continues to dominate the home healthcare market, anticipated to capture a significant revenue share of over 60% in 2024. This segment is divided into skilled and unskilled home healthcare services. Skilled services are delivered by licensed healthcare professionals, while unskilled services provide non-medical support, such as basic assistance or personal care services, helping home-bound patients with daily living tasks. The rising costs of hospital admissions are expected to drive further demand for skilled care services.

Skilled nursing services involve healthcare professionals, such as physicians, registered nurses, physiotherapists, and specialized caregivers, offering critical care in home settings or dedicated care facilities. With a growing elderly population suffering from chronic conditions like diabetes and cardiovascular diseases, there is an increasing need for essential medical services, including medication management and continuous monitoring. Advancements in medical technology now enable many treatments to be administered at home, providing patients with a more comfortable and convenient care environment. This is significantly fueling the growth of skilled home care services within the broader home healthcare market.

What Questions Should You Ask before Buying a Market Research Report?

How is the home healthcare market evolving?
What is driving and restraining the home healthcare market?
How will each home healthcare submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each home healthcare submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading home healthcare markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the home healthcare projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of
home healthcare projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the home healthcare market?
Where is the home healthcare market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the home healthcare market today, and over the next 10 years:

Our 370-page report provides 122 tables and 158 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces
Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Type
Product
Diagnostic: Blood Glucose Monitors, Pulse Oximeters, Blood Pressure Monitors, Others
Treatment: Home Dialysis Machine, Infusion Pumps, Nebulizers, Oxygen Concentrators, Wheelchairs & Scooters, Walking Aid Devices, Others
Services
Skilled Home Healthcare: Physician Primary Care, Nursing Care, Physical/Occupational/Speech Therapy, Nutritional Support & Infusion Therapy, Hospice & Palliative, Others
Unskilled Home Healthcare
Indication
Cardiovascular Disorder & Hypertension
Diabetes & Kidney Disorders
Neurological & Mental Disorders
Respiratory Disease & COPD
Maternal Disorders
Mobility Disorders
Cancer
Wound Care
Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA

The report also includes profiles for some of the leading companies in the Home Healthcare Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth
Abbott
Amedisys
Owens & Minor, Inc.
B. Braun Medical Ltd.
Baxter
BAYADA Home Health Care
Koninklijke Philips N.V.
Fisher & Paykel Healthcare Limited
Fresenius Medical Care AG
GE HealthCare
Johnson & Johnson Services, Inc.
OMRON Corporation
McKesson Medical-Surgical Inc.
Medline
Medtronic
3M Health Care
ARKRAY, Inc.
BD
Invacare Corporation
Hollister Incorporated
Convatec Group PLC
Molnlycke AB

Overall world revenue for Home Healthcare Market, 2024 to 2034 in terms of value the market will surpass US$400 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Home Healthcare Market, 2024 to 2034 report help you?
In summary, our 370+ page report provides you with the following knowledge:
Revenue forecasts to 2034 for Home Healthcare Market 2024 to 2034, with forecasts for Type and Indication, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Home Healthcare Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 23 of the major companies involved in the Home Healthcare Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Home Healthcare Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

1 Report Overview

1.1 Objectives of the Study
1.2 Introduction to Home Healthcare Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
  - 1.7.3.1 Primary Research
  - 1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview

3.1 Key Findings
3.2 Impact Analysis
3.3 Market Driving Factors
- 3.3.1 Rising Demand for Cost-Effective and Patient-Centred Healthcare Solutions
- 3.3.2 Technological Advancements in Telehealth and Remote Monitoring Devices
- 3.3.3 Increasing Prevalence of Chronic Diseases Requiring Ongoing Home Care
- 3.3.4 Growing Geriatric Population Preferring to Receive Care at Home
- 3.3.5 Supportive Government Initiatives Promoting Home Healthcare Services
3.4 Market Restraining Factors
- 3.4.1 Challenges Related to Reimbursement Policies for Home Healthcare Services
- 3.4.2 Regulatory Hurdles Impacting the Approval and Usage of Home Care Products
- 3.4.3 Limited Awareness and Acceptance of Home Healthcare Solutions Among Patients
3.5 Market Opportunities
- 3.5.1 Expansion of Digital Health Solutions Enhancing Remote Patient Management
- 3.5.2 Increasing Partnerships Between Healthcare Providers and Technology Companies
- 3.5.3 Growing Interest in Preventive Healthcare and Wellness Programs
3.6 Emerging Markets and Megatrends
3.7 Porter's Five Forces Analysis
- 3.7.1 Bargaining Power of Suppliers
- 3.7.2 Bargaining Power of Buyers
- 3.7.3 Competitive Rivalry
- 3.7.4 Threat of Substitutes
- 3.7.5 Threat of New Entrants
3.8 PEST Analysis

4 Home Healthcare Market Analysis by Type

4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Home Healthcare Market Size Estimation and Forecast by Type
4.4 Product
- 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Services
- 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Home Healthcare Market Analysis by Indication

5.1 Key Findings
5.2 Indication Segment: Market Attractiveness Index
5.3 Home Healthcare Market Size Estimation and Forecast by Indication
5.4 Cardiovascular Disorder & Hypertension
- 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Diabetes & Kidney Disorders
- 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Neurological & Mental Disorders
- 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Respiratory Disease & COPD
- 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Maternal Disorders
- 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Mobility Disorders
- 5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.9.2 Market Share by Region, 2024 & 2034 (%)
5.10 Cancer
- 5.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.10.2 Market Share by Region, 2024 & 2034 (%)
5.11 Wound Care
- 5.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.11.2 Market Share by Region, 2024 & 2034 (%)
5.12 Others
- 5.12.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.12.2 Market Share by Region, 2024 & 2034 (%)

6 Home Healthcare Market Analysis by Region

6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast

7 North America Home Healthcare Market Analysis

7.1 Key Findings
7.2 North America Home Healthcare Market Attractiveness Index
7.3 North America Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
7.4 North America Home Healthcare Market Size Estimation and Forecast by Country
7.5 North America Home Healthcare Market Size Estimation and Forecast by Type
7.6 North America Home Healthcare Market Size Estimation and Forecast by Indication
7.7 U.S. Home Healthcare Market Analysis
7.8 Canada Home Healthcare Market Analysis

8 Europe Home Healthcare Market Analysis

8.1 Key Findings
8.2 Europe Home Healthcare Market Attractiveness Index
8.3 Europe Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 Europe Home Healthcare Market Size Estimation and Forecast by Country
8.5 Europe Home Healthcare Market Size Estimation and Forecast by Type
8.6 Europe Home Healthcare Market Size Estimation and Forecast by Indication
8.7 Germany Home Healthcare Market Analysis
8.8 UK Home Healthcare Market Analysis
8.9 France Home Healthcare Market Analysis
8.10 Italy Home Healthcare Market Analysis
8.11 Spain Home Healthcare Market Analysis
8.12 Russia Home Healthcare Market Analysis
8.13 Rest of Europe Home Healthcare Market Analysis

9 Asia Pacific Home Healthcare Market Analysis

9.1 Key Findings
9.2 Asia Pacific Home Healthcare Market Attractiveness Index
9.3 Asia Pacific Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Asia Pacific Home Healthcare Market Size Estimation and Forecast by Country
9.5 Asia Pacific Home Healthcare Market Size Estimation and Forecast by Type
9.6 Asia Pacific Home Healthcare Market Size Estimation and Forecast by Indication
9.7 Japan Home Healthcare Market Analysis
9.8 China Home Healthcare Market Analysis
9.9 India Home Healthcare Market Analysis
9.10 Australia Home Healthcare Market Analysis
9.11 South Korea Home Healthcare Market Analysis
9.12 Rest of Asia Pacific Home Healthcare Market Analysis

10 Latin America Home Healthcare Market Analysis

10.1 Key Findings
10.2 Latin America Home Healthcare Market Attractiveness Index
10.3 Latin America Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Latin America Home Healthcare Market Size Estimation and Forecast by Country
10.5 Latin America Home Healthcare Market Size Estimation and Forecast by Type
10.6 Latin America Home Healthcare Market Size Estimation and Forecast by Indication
10.7 Brazil Home Healthcare Market Analysis
10.8 Mexico Home Healthcare Market Analysis
10.9 Argentina Home Healthcare Market Analysis
10.10 Colombia Home Healthcare Market Analysis
10.11 Rest of Latin America Home Healthcare Market Analysis

11 MEA Home Healthcare Market Analysis

11.1 Key Findings
11.2 MEA Home Healthcare Market Attractiveness Index
11.3 MEA Home Healthcare Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 MEA Home Healthcare Market Size Estimation and Forecast by Country
11.5 MEA Home Healthcare Market Size Estimation and Forecast by Type
11.6 MEA Home Healthcare Market Size Estimation and Forecast by Indication
11.7 GCC Home Healthcare Market Analysis
11.8 South Africa Home Healthcare Market Analysis
11.9 Rest of MEA Home Healthcare Market Analysis

12 Company Profiles

12.1 Abbott
- 12.1.1 Company Snapshot
- 12.1.2 Company Overview
- 12.1.3 Company Financials
  - 12.1.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.1.3.2 R&D, 2021-2023 (US$ Million)
  - 12.1.3.3 Regional Shares, 2023 (%)
  - 12.1.3.4 Business Segment Market Shares, 2023 (%)
- 12.1.4 Product Benchmarking
- 12.1.5 Strategic Outlook
12.2 Amedisys
- 12.2.1 Company Snapshot
- 12.2.2 Company Overview
- 12.2.3 Company Financials
  - 12.2.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.2.3.2 R&D, 2021-2023 (US$ Million)
  - 12.2.3.3 Regional Shares, 2023 (%)
  - 12.2.3.4 Business Segment Market Shares, 2023 (%)
- 12.2.4 Product Benchmarking
- 12.2.5 Strategic Outlook
12.3 Owens & Minor, Inc.
- 12.3.1 Company Snapshot
- 12.3.2 Company Overview
- 12.3.3 Company Financials
  - 12.3.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.3.3.2 R&D, 2021-2023 (US$ Million)
  - 12.3.3.3 Regional Shares, 2023 (%)
  - 12.3.3.4 Business Segment Market Shares, 2023 (%)
- 12.3.4 Product Benchmarking
- 12.3.5 Strategic Outlook
12.4 B. Braun Medical Ltd.
- 12.4.1 Company Snapshot
- 12.4.2 Company Overview
- 12.4.3 Company Financials
  - 12.4.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.4.3.2 R&D, 2021-2023 (US$ Million)
  - 12.4.3.3 Regional Shares, 2023 (%)
  - 12.4.3.4 Business Segment Market Shares, 2023 (%)
- 12.4.4 Product Benchmarking
- 12.4.5 Strategic Outlook
12.5 Baxter
- 12.5.1 Company Snapshot
- 12.5.2 Company Overview
- 12.5.3 Company Financials
  - 12.5.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.5.3.2 R&D, 2021-2023 (US$ Million)
  - 12.5.3.3 Regional Shares, 2023 (%)
  - 12.5.3.4 Business Segment Market Shares, 2023 (%)
- 12.5.4 Product Benchmarking
- 12.5.5 Strategic Outlook
12.6 BAYADA Home Health Care
- 12.6.1 Company Snapshot
- 12.6.2 Company Overview
- 12.6.3 Company Financials
  - 12.6.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.6.3.2 R&D, 2021-2023 (US$ Million)
  - 12.6.3.3 Regional Shares, 2023 (%)
  - 12.6.3.4 Business Segment Market Shares, 2023 (%)
- 12.6.4 Product Benchmarking
- 12.6.5 Strategic Outlook
12.7 ResMed
- 12.7.1 Company Snapshot
- 12.7.2 Company Overview
- 12.7.3 Company Financials
  - 12.7.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.7.3.2 R&D, 2021-2023 (US$ Million)
  - 12.7.3.3 Regional Shares, 2023 (%)
  - 12.7.3.4 Business Segment Market Shares, 2023 (%)
- 12.7.4 Product Benchmarking
- 12.7.5 Strategic Outlook
12.8 Koninklijke Philips N.V.
- 12.8.1 Company Snapshot
- 12.8.2 Company Overview
- 12.8.3 Company Financials
  - 12.8.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.8.3.2 R&D, 2021-2023 (US$ Million)
  - 12.8.3.3 Regional Shares, 2023 (%)
  - 12.8.3.4 Business Segment Market Shares, 2023 (%)
- 12.8.4 Product Benchmarking
- 12.8.5 Strategic Outlook
12.9 Fisher & Paykel Healthcare Limited
- 12.9.1 Company Snapshot
- 12.9.2 Company Overview
- 12.9.3 Company Financials
  - 12.9.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.9.3.2 R&D, 2021-2023 (US$ Million)
  - 12.9.3.3 Regional Shares, 2023 (%)
  - 12.9.3.4 Business Segment Market Shares, 2023 (%)
- 12.9.4 Product Benchmarking
- 12.9.5 Strategic Outlook
12.10 Fresenius Medical Care AG
- 12.10.1 Company Snapshot
- 12.10.2 Company Overview
- 12.10.3 Company Financials
  - 12.10.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.10.3.2 R&D, 2021-2023 (US$ Million)
  - 12.10.3.3 Regional Shares, 2023 (%)
  - 12.10.3.4 Business Segment Market Shares, 2023 (%)
- 12.10.4 Product Benchmarking
- 12.10.5 Strategic Outlook
12.11 GE HealthCare
- 12.11.1 Company Snapshot
- 12.11.2 Company Overview
- 12.11.3 Company Financials
  - 12.11.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.11.3.2 R&D, 2021-2023 (US$ Million)
  - 12.11.3.3 Regional Shares, 2023 (%)
  - 12.11.3.4 Business Segment Market Shares, 2023 (%)
- 12.11.4 Product Benchmarking
- 12.11.5 Strategic Outlook
12.12 Johnson & Johnson Services, Inc.
- 12.12.1 Company Snapshot
- 12.12.2 Company Overview
- 12.12.3 Company Financials
  - 12.12.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.12.3.2 R&D, 2021-2023 (US$ Million)
  - 12.12.3.3 Regional Shares, 2023 (%)
  - 12.12.3.4 Business Segment Market Shares, 2023 (%)
- 12.12.4 Product Benchmarking
- 12.12.5 Strategic Outlook
12.13 OMRON Corporation
- 12.13.1 Company Snapshot
- 12.13.2 Company Overview
- 12.13.3 Company Financials
  - 12.13.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.13.3.2 R&D, 2021-2023 (US$ Million)
  - 12.13.3.3 Regional Shares, 2023 (%)
  - 12.13.3.4 Business Segment Market Shares, 2023 (%)
- 12.13.4 Product Benchmarking
- 12.13.5 Strategic Outlook
12.14 McKesson Medical-Surgical Inc.
- 12.14.1 Company Snapshot
- 12.14.2 Company Overview
- 12.14.3 Company Financials
  - 12.14.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.14.3.2 R&D, 2021-2023 (US$ Million)
  - 12.14.3.3 Regional Shares, 2023 (%)
  - 12.14.3.4 Business Segment Market Shares, 2023 (%)
- 12.14.4 Product Benchmarking
- 12.14.5 Strategic Outlook
12.15 Medline
- 12.15.1 Company Snapshot
- 12.15.2 Company Overview
- 12.15.3 Company Financials
  - 12.15.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.15.3.2 R&D, 2021-2023 (US$ Million)
  - 12.15.3.3 Regional Shares, 2023 (%)
  - 12.15.3.4 Business Segment Market Shares, 2023 (%)
- 12.15.4 Product Benchmarking
- 12.15.5 Strategic Outlook
12.16 Medtronic
- 12.16.1 Company Snapshot
- 12.16.2 Company Overview
- 12.16.3 Company Financials
  - 12.16.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.16.3.2 R&D, 2021-2023 (US$ Million)
  - 12.16.3.3 Regional Shares, 2023 (%)
  - 12.16.3.4 Business Segment Market Shares, 2023 (%)
- 12.16.4 Product Benchmarking
- 12.16.5 Strategic Outlook
12.17 3M Health Care
- 12.17.1 Company Snapshot
- 12.17.2 Company Overview
- 12.17.3 Company Financials
  - 12.17.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.17.3.2 R&D, 2021-2023 (US$ Million)
  - 12.17.3.3 Regional Shares, 2023 (%)
  - 12.17.3.4 Business Segment Market Shares, 2023 (%)
- 12.17.4 Product Benchmarking
- 12.17.5 Strategic Outlook
12.18 ARKRAY, Inc.
- 12.18.1 Company Snapshot
- 12.18.2 Company Overview
- 12.18.3 Company Financials
  - 12.18.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.18.3.2 R&D, 2021-2023 (US$ Million)
  - 12.18.3.3 Regional Shares, 2023 (%)
  - 12.18.3.4 Business Segment Market Shares, 2023 (%)
- 12.18.4 Product Benchmarking
- 12.18.5 Strategic Outlook
12.19 BD
- 12.19.1 Company Snapshot
- 12.19.2 Company Overview
- 12.19.3 Company Financials
  - 12.19.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.19.3.2 R&D, 2021-2023 (US$ Million)
  - 12.19.3.3 Regional Shares, 2023 (%)
  - 12.19.3.4 Business Segment Market Shares, 2023 (%)
- 12.19.4 Product Benchmarking
- 12.19.5 Strategic Outlook
12.20 Invacare Corporation
- 12.20.1 Company Snapshot
- 12.20.2 Company Overview
- 12.20.3 Company Financials
  - 12.20.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.20.3.2 R&D, 2021-2023 (US$ Million)
  - 12.20.3.3 Regional Shares, 2023 (%)
  - 12.20.3.4 Business Segment Market Shares, 2023 (%)
- 12.20.4 Product Benchmarking
- 12.20.5 Strategic Outlook
12.21 Hollister Incorporated
- 12.21.1 Company Snapshot
- 12.21.2 Company Overview
- 12.21.3 Company Financials
  - 12.21.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.21.3.2 R&D, 2021-2023 (US$ Million)
  - 12.21.3.3 Regional Shares, 2023 (%)
  - 12.21.3.4 Business Segment Market Shares, 2023 (%)
- 12.21.4 Product Benchmarking
- 12.21.5 Strategic Outlook
12.22 Convatec Group PLC
- 12.22.1 Company Snapshot
- 12.22.2 Company Overview
- 12.22.3 Company Financials
  - 12.22.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.22.3.2 R&D, 2021-2023 (US$ Million)
  - 12.22.3.3 Regional Shares, 2023 (%)
  - 12.22.3.4 Business Segment Market Shares, 2023 (%)
- 12.22.4 Product Benchmarking
- 12.22.5 Strategic Outlook
12.23 Molnlycke AB
- 12.23.1 Company Snapshot
- 12.23.2 Company Overview
- 12.23.3 Company Financials
  - 12.23.3.1 Revenue, 2021-2023 (US$ Million)
  - 12.23.3.2 R&D, 2021-2023 (US$ Million)
  - 12.23.3.3 Regional Shares, 2023 (%)
  - 12.23.3.4 Business Segment Market Shares, 2023 (%)
- 12.23.4 Product Benchmarking
- 12.23.5 Strategic Outlook

13 Conclusion and Recommendations

13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players

簡介目錄圖表

List of Tables

Table 1 Home Healthcare Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 3 Product Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 4 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 5 Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 6 Cardiovascular Disorder & Hypertension Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 7 Diabetes & Kidney Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 8 Neurological & Mental Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 9 Respiratory Disease & COPD Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 10 Maternal Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 11 Mobility Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 12 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 13 Wound Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 14 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 15 Home Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 16 North America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 17 North America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 18 North America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 19 U.S. Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 20 Canada Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 21 Europe Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 22 Europe Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 23 Europe Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 24 Germany Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 25 UK Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 26 France Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 27 Italy Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 28 Spain Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 29 Russia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 30 Rest of Europe Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 31 Asia Pacific Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 32 Asia Pacific Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 33 Asia Pacific Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 34 Japan Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 35 China Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 36 India Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 37 Australia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 38 South Korea Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 39 Rest of Asia Pacific Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 40 Latin America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 41 Latin America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 42 Latin America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 43 Brazil Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 44 Mexico Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 45 Argentina Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 46 Colombia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 47 Rest of Latin America Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 48 MEA Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 49 MEA Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 50 MEA Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 51 GCC Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 52 South Africa Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 53 Rest of MEA Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
Table 54 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 55 Abbott: Product Benchmarking
Table 56 Abbott: Strategic Outlook
Table 57 Amedisys, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 58 Amedisys, Inc.: Product Benchmarking
Table 59 Amedisys, Inc.: Strategic Outlook
Table 60 Owens & Minor, Inc. Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 61 Owens & Minor, Inc. Product Benchmarking
Table 62 Owens & Minor, Inc. Strategic Outlook
Table 63 B. Braun Medical Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 64 B. Braun Medical Ltd.: Product Benchmarking
Table 65 B. Braun Medical Ltd.: Strategic Outlook
Table 66 Baxter: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Baxter: Product Benchmarking
Table 68 Baxter: Strategic Outlook
Table 69 BAYADA Home Health Care: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 BAYADA Home Health Care: Product Benchmarking
Table 71 BAYADA Home Health Care: Strategic Outlook
Table 72 ResMed: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 ResMed: Product Benchmarking
Table 74 ResMed: Strategic Outlook
Table 75 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Koninklijke Philips N.V.: Product Benchmarking
Table 77 Koninklijke Philips N.V.: Strategic Outlook
Table 78 Fisher & Paykel Healthcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Fisher & Paykel Healthcare Limited: Product Benchmarking
Table 80 Fisher & Paykel Healthcare Limited: Strategic Outlook
Table 81 Fresenius Medical Care AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Fresenius Medical Care AG: Product Benchmarking
Table 83 Fresenius Medical Care AG: Strategic Outlook
Table 84 GE HealthCare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 GE HealthCare: Product Benchmarking
Table 86 GE HealthCare: Strategic Outlook
Table 87 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 89 Johnson & Johnson Services, Inc.: Strategic Outlook
Table 90 OMRON Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 OMRON Corporation: Product Benchmarking
Table 92 OMRON Corporation: Strategic Outlook
Table 93 McKesson Medical-Surgical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 McKesson Medical-Surgical Inc.: Product Benchmarking
Table 95 McKesson Medical-Surgical Inc.: Strategic Outlook
Table 96 Medline: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Medline: Product Benchmarking
Table 98 Medline: Strategic Outlook
Table 99 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Medtronic: Product Benchmarking
Table 101 Medtronic: Strategic Outlook
Table 102 3M Health Care: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 3M Health Care: Product Benchmarking
Table 104 3M Health Care: Strategic Outlook
Table 105 ARKRAY, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 ARKRAY, Inc.: Product Benchmarking
Table 107 ARKRAY, Inc.: Strategic Outlook
Table 108 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 BD: Product Benchmarking
Table 110 BD: Strategic Outlook
Table 111 Invacare Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Invacare Corporation: Product Benchmarking
Table 113 Invacare Corporation: Strategic Outlook
Table 114 Hollister Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Hollister Incorporated: Product Benchmarking
Table 116 Hollister Incorporated: Strategic Outlook
Table 117 Convatec Group PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Convatec Group PLC: Product Benchmarking
Table 119 Convatec Group PLC: Strategic Outlook
Table 120 Molnlycke AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Molnlycke AB: Product Benchmarking
Table 122 Molnlycke AB: Strategic Outlook

List of Figures

Figure 1 Home Healthcare Market Segmentation
Figure 2 Home Healthcare Market by Type: Market Attractiveness Index
Figure 3 Home Healthcare Market by Indication: Market Attractiveness Index
Figure 4 Home Healthcare Market Attractiveness Index by Region
Figure 5 Home Healthcare Market: Market Dynamics
Figure 6 Home Healthcare Market: Porter's Five Forces Analysis
Figure 7 Home Healthcare Market: PEST Analysis
Figure 8 Home Healthcare Market Attractiveness Index by Type
Figure 9 Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 10 Home Healthcare Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 11 Product Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 12 Product Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 13 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 14 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 15 Home Healthcare Market Attractiveness Index by Indication
Figure 16 Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
Figure 17 Home Healthcare Market Share Forecast by Indication, 2024, 2029, 2034 (%)
Figure 18 Cardiovascular Disorder & Hypertension Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 19 Cardiovascular Disorder & Hypertension Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Diabetes & Kidney Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 21 Diabetes & Kidney Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Neurological & Mental Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Neurological & Mental Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Respiratory Disease & COPD Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 25 Respiratory Disease & COPD Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Maternal Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 27 Maternal Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 28 Mobility Disorders Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 29 Mobility Disorders Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 31 Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 32 Wound Care Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 33 Wound Care Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Home Healthcare Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
Figure 37 Home Healthcare Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 38 Home Healthcare Market by Region, 2024-2034 (US$ Bn, AGR %)
Figure 39 North America Home Healthcare Market Attractiveness Index
Figure 40 North America Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 41 North America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 42 North America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 43 North America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
Figure 44 U.S. Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 45 Canada Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 46 Europe Home Healthcare Market Attractiveness Index
Figure 47 Europe Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 48 Europe Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 49 Europe Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 50 Europe Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
Figure 51 Germany Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 52 UK Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 53 France Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 54 Italy Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 55 Spain Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 56 Russia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 57 Rest of Europe Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 58 Asia Pacific Home Healthcare Market Attractiveness Index
Figure 59 Asia Pacific Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 60 Asia Pacific Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 61 Asia Pacific Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 62 Asia Pacific Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
Figure 63 Japan Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 64 China Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 65 India Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 66 Australia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 67 South Korea Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 68 Rest of Asia Pacific Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 69 Latin America Home Healthcare Market Attractiveness Index
Figure 70 Latin America Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 71 Latin America Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 72 Latin America Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 73 Latin America Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
Figure 74 Brazil Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 75 Mexico Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 76 Argentina Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 77 Colombia Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 78 Rest of Latin America Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 79 MEA Home Healthcare Market Attractiveness Index
Figure 80 MEA Home Healthcare Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 81 MEA Home Healthcare Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 82 MEA Home Healthcare Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 83 MEA Home Healthcare Market Forecast by Indication, 2024-2034 (US$ Billion, AGR %)
Figure 84 GCC Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 85 South Africa Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 86 Rest of MEA Home Healthcare Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 87 Abbott: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 88 Abbott: Regional Market Shares (%), 2023
Figure 89 Abbott: R&D, 2021-2023 (US$ Million, AGR %)
Figure 90 Abbott: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 91 Abbott: Regional Market Shares (%), 2023
Figure 92 Abbott: R&D, 2021-2023 (US$ Million, AGR %)
Figure 93 Amedisys, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 94 Amedisys, Inc.: Regional Market Shares (%), 2023
Figure 95 Amedisys, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 96 Owens & Minor, Inc. Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 97 Owens & Minor, Inc. Regional Market Shares (%), 2023
Figure 98 Owens & Minor, Inc. R&D, 2021-2023 (US$ Million, AGR %)
Figure 99 B. Braun Medical Ltd.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 100 B. Braun Medical Ltd.: Regional Market Shares (%), 2023
Figure 101 B. Braun Medical Ltd.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 102 Baxter: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 103 Baxter: Regional Market Shares (%), 2023
Figure 104 Baxter: R&D, 2021-2023 (US$ Million, AGR %)
Figure 105 BAYADA Home Health Care: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 106 BAYADA Home Health Care: Regional Market Shares (%), 2023
Figure 107 BAYADA Home Health Care: R&D, 2021-2023 (US$ Million, AGR %)
Figure 108 ResMed: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 109 ResMed: Regional Market Shares (%), 2023
Figure 110 ResMed: R&D, 2021-2023 (US$ Million, AGR %)
Figure 111 Koninklijke Philips N.V.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 112 Koninklijke Philips N.V.: Regional Market Shares (%), 2023
Figure 113 Koninklijke Philips N.V.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 114 Fisher & Paykel Healthcare Limited: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 115 Fisher & Paykel Healthcare Limited: Regional Market Shares (%), 2023
Figure 116 Fisher & Paykel Healthcare Limited: R&D, 2021-2023 (US$ Million, AGR %)
Figure 117 Fresenius Medical Care AG: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 118 Fresenius Medical Care AG: Regional Market Shares (%), 2023
Figure 119 Fresenius Medical Care AG: R&D, 2021-2023 (US$ Million, AGR %)
Figure 120 GE HealthCare: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 121 GE HealthCare: Regional Market Shares (%), 2023
Figure 122 GE HealthCare: R&D, 2021-2023 (US$ Million, AGR %)
Figure 123 Johnson & Johnson Services, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 124 Johnson & Johnson Services, Inc.: Regional Market Shares (%), 2023
Figure 125 Johnson & Johnson Services, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 126 OMRON Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 127 OMRON Corporation: Regional Market Shares (%), 2023
Figure 128 OMRON Corporation: R&D, 2021-2023 (US$ Million, AGR %)
Figure 129 McKesson Medical-Surgical Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 130 McKesson Medical-Surgical Inc.: Regional Market Shares (%), 2023
Figure 131 McKesson Medical-Surgical Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 132 Medline: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 133 Medline: Regional Market Shares (%), 2023
Figure 134 Medline: R&D, 2021-2023 (US$ Million, AGR %)
Figure 135 Medtronic: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 136 Medtronic: Regional Market Shares (%), 2023
Figure 137 Medtronic: R&D, 2021-2023 (US$ Million, AGR %)
Figure 138 3M Health Care: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 139 3M Health Care: Regional Market Shares (%), 2023
Figure 140 3M Health Care: R&D, 2021-2023 (US$ Million, AGR %)
Figure 141 ARKRAY, Inc.: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 142 ARKRAY, Inc.: Regional Market Shares (%), 2023
Figure 143 ARKRAY, Inc.: R&D, 2021-2023 (US$ Million, AGR %)
Figure 144 BD: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 145 BD: Regional Market Shares (%), 2023
Figure 146 BD: R&D, 2021-2023 (US$ Million, AGR %)
Figure 147 Invacare Corporation: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 148 Invacare Corporation: Regional Market Shares (%), 2023
Figure 149 Invacare Corporation: R&D, 2021-2023 (US$ Million, AGR %)
Figure 150 Hollister Incorporated: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 151 Hollister Incorporated: Regional Market Shares (%), 2023
Figure 152 Hollister Incorporated: R&D, 2021-2023 (US$ Million, AGR %)
Figure 153 Convatec Group PLC: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 154 Convatec Group PLC: Regional Market Shares (%), 2023
Figure 155 Convatec Group PLC: R&D, 2021-2023 (US$ Million, AGR %)
Figure 156 Molnlycke AB: Net Revenue, 2021-2023 (US$ Million, AGR %)
Figure 157 Molnlycke AB: Regional Market Shares (%), 2023
Figure 158 Molnlycke AB: R&D, 2021-2023 (US$ Million, AGR %)